Skip to content

Smart wound dressing fights infections by releasing antibiotics on demand

What if a bandage could sense infection and strike back? Scientists developed a hydrogel that attacks dangerous bacteria while sparing the good ones—saving lives and antibiotics.

The image shows a large first-aid dressing box on a white surface. The box is rectangular in shape...
The image shows a large first-aid dressing box on a white surface. The box is rectangular in shape and has a label on the front with the words "Large First-Aid Dressing" printed in bold black lettering. The lid of the box is slightly ajar, revealing the contents inside.

Smart wound dressing fights infections by releasing antibiotics on demand

Scientists have created a smart wound dressing that releases antibiotics only when harmful bacteria are detected. The new hydrogel material could help fight antibiotic resistance by targeting infections more precisely than traditional treatments. The research team developed a hydrogel loaded with antibiotic nanoparticles. Unlike standard dressings, this material stays intact until it encounters beta-lactamases—enzymes produced by dangerous bacteria. Once triggered, the gel breaks down and releases its antibiotic payload, leaving harmless bacteria unaffected.

Tests in petri dishes confirmed the hydrogel's selective response. It degraded only when exposed to beta-lactamase-producing bacteria, not in the presence of safe microbial strains. In further experiments on mice, a single application eliminated infection in an abrasion wound. The new dressing outperformed a widely used antimicrobial dressing in both killing bacteria and speeding up healing. With over 1 million global deaths each year from antibiotic-resistant infections, solutions like this are urgently needed. The problem could worsen, with projections of 10 million annual deaths by 2050 if overuse continues. The project received funding from the Dr. Ralph and Marian Falk Medical Research Trust. The team has already patented the material and is now working on commercial development.

This selective hydrogel could reduce unnecessary antibiotic use by targeting infections more effectively. The technology has shown promise in lab and animal tests, offering a potential tool against rising resistance. Further development may bring it to clinical use in the future.

Latest